TTK Healthcare Ltd. Stock Falls to 52-Week Low of Rs.955.2 Amidst Prolonged Downtrend

Recent Price Movement and Market Context

On the trading day, TTK Healthcare’s share price touched an intraday low of Rs.955.2, representing a 2.73% drop from the previous close. The stock has been on a four-day losing streak, cumulatively falling by 5.26% during this period. This decline outpaced the sector’s underperformance, with TTK Healthcare lagging by 1.83% relative to its diversified sector peers.

Currently, the stock trades below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling a persistent bearish momentum. This technical positioning underscores the challenges faced by the stock in regaining upward traction.

Meanwhile, the broader market environment has also been subdued. The Sensex, after a flat opening with a marginal gain of 28.57 points, declined sharply by 784.72 points to close at 81,551.22, down 0.92%. Notably, the Sensex itself is trading below its 50-day moving average, although the 50-day average remains above the 200-day average, indicating mixed medium-term market signals.

Performance Overview and Valuation Metrics

Over the past year, TTK Healthcare has delivered a negative return of 26.28%, significantly underperforming the Sensex, which posted a positive 6.62% return over the same period. The stock’s 52-week high was Rs.1,402, highlighting the extent of the recent decline.

Despite the downward price movement, the company’s profits have shown a modest increase of 9.3% over the last year. However, this profit growth has not translated into positive market sentiment, as reflected in the stock’s price-to-earnings dynamics. The company’s PEG ratio stands at 2.1, indicating that the stock’s price growth has not kept pace with earnings growth, which may contribute to valuation concerns.

TTK Healthcare’s price-to-book value ratio is 1.3, suggesting that the stock trades at a premium relative to its book value. This premium is higher than the average historical valuations of its peers in the diversified sector, which may be a factor in the current market assessment.

Financial Health and Operational Indicators

The company maintains a low average debt-to-equity ratio of zero, reflecting a debt-free balance sheet. This conservative capital structure is a positive aspect amid market volatility. However, other financial indicators present a mixed picture.

Cash and cash equivalents at the half-year mark are reported at Rs.600.89 crores, the lowest level recorded in recent periods. Additionally, the debtors turnover ratio has declined to 7.40 times, the lowest in the half-year, signalling potential challenges in receivables management or collection efficiency.

Non-operating income constitutes a substantial 80.43% of the company’s profit before tax in the latest quarter, indicating that a significant portion of earnings is derived from sources outside core business activities. This reliance may affect the sustainability of profitability.

Market Participation and Shareholding Patterns

Domestic mutual funds hold a minimal stake of just 0.01% in TTK Healthcare, despite the company’s sizeable market capitalisation. Given that mutual funds typically conduct thorough research and maintain meaningful positions in companies they favour, this limited holding may reflect a cautious stance towards the stock’s current valuation and business outlook.

Furthermore, the stock has underperformed the BSE500 index across multiple time frames, including the last three years, one year, and three months, reinforcing the trend of below-par performance relative to broader market benchmarks.

Long-Term Growth and Sector Comparison

TTK Healthcare’s net sales have grown at an annualised rate of 7.36% over the past five years, a modest pace that has not translated into significant market appreciation. The company’s return on equity (ROE) stands at 6.5%, which, while positive, is moderate compared to sector averages.

The diversified sector itself has experienced mixed performance, with some indices such as NIFTY Realty also hitting new 52-week lows on the same day, indicating sector-wide pressures that may be influencing investor sentiment.

Overall, TTK Healthcare’s recent price action and financial metrics reflect a combination of subdued growth, valuation premiums, and cautious market participation, culminating in the stock’s decline to its lowest level in a year.

Summary of Key Data Points

• New 52-week low: Rs.955.2 (intraday low on 23 Jan 2026)
• Four consecutive days of price decline, total loss of 5.26%
• Underperformance relative to sector by 1.83% on the day
• Trading below all major moving averages (5, 20, 50, 100, 200 days)
• One-year return: -26.28% versus Sensex +6.62%
• Net sales growth (5 years CAGR): 7.36%
• ROE: 6.5%
• PEG ratio: 2.1
• Price-to-book value: 1.3
• Debt-to-equity ratio: 0 (average)
• Cash and cash equivalents (HY): Rs.600.89 crores
• Debtors turnover ratio (HY): 7.40 times
• Non-operating income as % of PBT (Q): 80.43%
• Domestic mutual fund holding: 0.01%
• Mojo Score: 37.0 (Sell), downgraded from Hold on 21 Jul 2025

These figures collectively illustrate the challenges faced by TTK Healthcare Ltd. in maintaining its market position and investor confidence amid a competitive and evolving sector landscape.

Unlock special upgrade rates for a limited period. Start Saving Now →